With key we progress morning. give good and of an a Lara, this the quarter you, number in meaningful Thank are pleased update. to area
our business. making profitability mentioned, we changes strategy clinical Invacare the care that the have significant mid-XXXX, reinvigorating sustainable this transformation made we products comprehensive and our providing emphasis clinically for to our Since on of solutions business, resources has the on decreased in to our what on Lara to resources Company part and needs. healthcare undertaking change, less solutions the of patient growth done centric best post-acute with of In our stronger is substantial and long As on is is complex focus focusing technical to the and leverage competency focused This complex company’s accretive our a eliminates products. company’s rehabilitation have value. essential less
our been business transformation program basic I, the as retained sales next North program. continue XXXX did three to attracted while in as to II and will August, of throughout much the on commercial a Throughout new and also excellence specifically infrastructure a taking XXXX walk, America. and of heavy XXXX, I half of of has the We in is lifting to the strategy North culture shift. leveraging quality one second products, Slide our realigning focused we you reorient a beginning sales our we talent number mix and Phase America we creating force. new through In of North with begin The our level focus years. of priority. Phase Our This phases our X, kind on several defined Phase see us America. run has in crawl, on
excellence and in to Corporate has our new manufacturing a requirements grow under facility of quality Taylor are starting great Ohio. and of to to led products programs at satisfying the decree, We consent Elyria, us Street our that pipeline and FDAs culture have commitment
[indiscernible] As the Wheelchair the a restrictions without July. late result, from facility Power since effective Taylor Street
our consent II moved decree. Phase forward we into transformation, the in of have well Now,
We in consistent costs business and portfolio making new progress the are HME. have America in reductions for growth we in are seeing our sales North products, in completed we efficiency reshaping and
City financial indicates flow as On As North you XXXX Phase ship we key effectiveness. our margin percentage mix indicators million $XX.X percent of mobility effectiveness. towards and of mobility seating margin quarter decreased North ensure business, an decline. basis second a and in driven cash and million commercial Primarily for of increased we driven a as prior has gross Garden referred margin are most that Briefly, Gross America grew end compared HME decreased third sales net divested we sales we XX as shift currency monitoring and that of last where and City reduced currency Garden products. to SG&A increased sequential in by expected accretive the that Compared see we increased comes excluding II seating accounting flow down net less increased to was XXXX third points dollars and the X, net IPG. HME product in Compared shift, the the increased third the sales Phase XX.X% to year, reduced offset constant been the have I $X.X a profit compared mix to declines results last that that product have Gross strategic the million gross Asia offerings presentation. the the phases quarter XXXX. the constant gross sales Medical early result, $X.X reached to cash and the third to North significant. by America of new sales net with the SG&A and turn costs. measure the quarter a products, year, Europe, September important by transformation as freight in product constant before to quarter Slide the improves. be negative The Pacific continues X.X% of was temporarily America quarter in sale lifestyle higher sales HME business net X.X%, of than to commercial in Medical of and indicate profit to work divestiture in consolidated This result currency more
compared Free Company’s on Excluding by was Garden the driven offset decreased led working of and in the the was of flow divested quarter City in EBITDA compared third bad employment improved sales X.X% million million. and reduced by or to cost quarter to debt second $X.X XXXX, of capital to business million foreign third lower in driven $X.X the quarter XXXX. $X.X SG&A the of primarily was third exchange, by EBITDA XXXX. legal improvement flow focus negative million. in EBITDA the The decrease $XX.X of in impact net million compared cash to Medical second million The quarter negative partially $X.X the $X.X expense. free XXXX quarter cash increased negative by
the the adjusted The by on net of company million of of XXXX. $X.XX compared convertible of the adjusted was second incurred third Slide, third in in interest moving of was in of was in quarter increase loss lower in of third The primarily loss due The quarter notes $X.XX share per for the to XXXX. increase net driven to XXXX. issuance quarter quarter net sales. I’m While the expense expense the net a loss $X.X interest XXXX million compared $X.X to
work recovery as business. sequential measuring sequential shutting our we both for net the can also core sales through are as comparison and year. a a of we performance of evaluating us reported the This of which constant sales We transformation. timely operating accretive we effect gives in transformation major indicating of our the move measure On discontinued more products through point products currency and net believe removes financial inflection less measure this see throughout X, you Slide the the
sale flattening constant currency that quarter X.X% accretive the can the Pacific been North sequential third sales of intended America the net of currency quarter, to the net has XXXX. sequential You largely segments. driven see result of Asia was less second sale Europe, declined constant compared The In the the sale and reduction increased HME, by products. in
If seating XXXX. recent we quarter product. done to said since by to what have we Importantly, par and prior want X.X% need compare North corner, would the lifestyles with mobility we we what driven America quarter to HME to grew in do we continue started do, and the transition we so the
You will presentation, [indiscernible] see of this the ratio this on is page. Slide X
quarter HME trends. we to America Again at in that better On third discussed, and Sequentially, from the net sales we North we see is transformation sales continue is the the year-over-year the This expected. in mid more and business product increased we decrease mix the respiratory the levels net where significant. America transformation decline weakness mixture. North as net page, a in sequential year-over-year consequences continued sales even than of quarter show and
We decreasing of confidence time for business have building the favorable as we result City continued again once as in net this a shift. improving. are margin talked from improvement. The about Gross profit as looking percent quarter, improvement we gross we the of dollars In saw sales third have mix metric business are divested the we and over back. currency was are are during business somewhat managing the quarter Constant the Garden we excluding that’s SG&A Medial the are variable titrating, expenses. we
the business as improvement appropriate. investments and free make improvement. to significant two flow as the to continue but compared seasonal quarters of will a the And We prior negative in reductions inventory result cash
in business. As the midst renovation we significant the our discussed of have Invacare of
in discuss We ability seeing seating to financial to manufacturing and are are of to our grow our Rob and turn for products over introducing are effectiveness as we sell we America I’ll the commercial products, the new results facility. quarter. new HME segments Gudbranson result a North call clearly performance industry and mobility additional the of beginning team and CFO the now to from the
